Inhibiting extracellular vesicles formation and release: a review of EV inhibitors

Cited by papers we hold 13

• Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer · 2024
  No notice
• Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches · 2024
  No notice
• Pre-metastatic niche: formation, characteristics and therapeutic implication · 2024
  No notice
• Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle · 2022
  No notice
• Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction · 2022
  No notice
• Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy · 2022
  No notice
• Exosome-Mediated Immunosuppression in Tumor Microenvironments · 2022
  No notice
• Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys · 2021
  No notice
• Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength · 2021
  No notice
• Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications · 2020
  No notice
• Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications · 2020
  No notice
• TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions · 2020
  No notice
• Bioactive DNA from extracellular vesicles and particles · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.